Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study

Overview of attention for article published in Cardiovascular Diabetology, November 2013

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 9,878 followers.

@iatros256395 Ça semble rassurant ? https://t.co/2dEMrstU9a Et quid de l'association ezetimibe/acide bempédoïque autorisée en 2020 (Nustendi) ?

ベザフィブラートとエゼチミブとの長期併用療法の安全性および有効性を調べた日本の前向き観察研究【Cardiovascular Diabetology】 http://t.co/5dlNSNCeY0

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.